At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Jul 20, 2026 at 16:32 ET
A cluster of insider sales at United Therapeutics shows the CEO and General Counsel selling shares, primarily to cover tax obligations from exercised options. The total open-market sales of ~$349K represent a trivial 0.0015% of the $22.7B market cap, making this a routine, non-informational event.
- CEO Martine Rothblatt sold ~$4.5M in open-market shares on July 17, 2026, but these were part of a larger option exercise (9,500 shares at $0) and a cash exercise (9,500 shares at $135.42), with the sales primarily covering tax withholding.
- EVP Paul Mahon sold ~$1.8M in open-market shares on July 16, 2026, also tied to option exercises (8,300 shares at $146.03 and 8,300 shares at $0).
- Director Jan Malcolm sold $179K in open-market shares on July 10, 2026, a standalone sale not linked to option exercises.
- Total open-market sales in the cluster are ~$349K, which is 0.0015% of UTHR's $22.7B market cap, a trivial amount.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access